2024 |
ARS Pharmaceuticals Inc
|
Independent Director |
287.9 K |
15.1 % |
2024 |
Passage Bio Inc
|
Independent Director |
92.5 K |
40.5 % |
2024 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |
2023 |
ARS Pharmaceuticals Inc
|
Independent Director |
250.1 K |
67.8 % |
2023 |
Passage Bio Inc
|
- |
65.8 K |
-16.2 % |
2023 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |
2022 |
ARS Pharmaceuticals Inc
|
Director |
149.1 K |
- |
2022 |
Passage Bio Inc
|
Independent Director |
78.6 K |
-64.0 % |
2022 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |
2021 |
Passage Bio Inc
|
Independent Director |
218.5 K |
-19.7 % |
2021 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |
2020 |
Passage Bio Inc
|
Independent Director |
271.9 K |
-54.4 % |
2020 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |
2019 |
Passage Bio Inc
|
Independent Director |
596.3 K |
- |
2019 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |
2018 |
SpringWorks Therapeutics Inc
|
Director and Chief Executive Officer |
- |
- |